Chief executive, Precision Medicine Group
Appears in 1 story
Will lead Precision into McKesson's Oncology & Multispecialty segment
The largest US drug distributor, McKesson, agreed on August 25 to buy Precision Medicine Group for $2.25 billion. Precision runs clinical trials, biomarker labs, and payer-negotiation services for biotechnology and pharmaceutical companies.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
